Skip to content

Clinical trials

Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Clear all

2,362 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200037
200133
200236
200339
200457
200562
200666
200774
200872
200980
201080
201174
201289
201369
201491
201589
2016111
2017112
201893
2019100
2020112
2021103
2022115
2023119
202493
2025117
2026114

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,074
Recruiting364
Terminated280
Unknown status268
Active, not recruiting165
Withdrawn104
Not yet recruiting79
Suspended14
Enrolling by invitation11
Available2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)136
M.D. Anderson Cancer Center87
Duke University66
Memorial Sloan Kettering Cancer Center51
Case Comprehensive Cancer Center29
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins28
Mayo Clinic27
Children's Oncology Group24
St. Jude Children's Research Hospital24
Massachusetts General Hospital21

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms2,362
Glioblastoma601
Glioma492
Astrocytoma306
Central Nervous System Neoplasms294
Gliosarcoma272
Oligodendroglioma212
Neoplasms201
Breast Neoplasms179
Neoplasm Metastasis158

Trials

Showing 1 to 25 of 2,362. Each trial links to its page on Pharma Observatory.

2,262 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.